Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
9.56
+0.03 (0.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $476.43 million as of February 21, 2025. Its market cap has decreased by -5.61% in one year.
Market Cap
476.43M
Enterprise Value
278.24M
1-Year Change
-5.61%
Ranking
Category
Stock Price
$9.56
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has decreased from $624.91M to $476.43M, a decrease of -23.76%. That is a compound annual growth rate of -12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 476.43M | -22.24% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |